Vimarsana
Biggest News Aggregation in the World

Anders Ekblom News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Anders Ekblom. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Anders Ekblom Today - Breaking & Trending Today

Mereo BioPharma : UK Annual Report 2023 - MarketScreener - Vimarsana News

Mereo BioPharma : UK Annual Report 2023 - MarketScreener

Company Number 09481161 MEREO BIOPHARMA GROUP PLC Annual Report and Accounts Year ended December 31, 2023 ...

Mereo BioPharma : THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION - Form 6-K -November 16, 2023 at 07:06 am EST - Vimarsana News

Mereo BioPharma : THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION - Form 6-K -November 16, 2023 at 07:06 am EST

THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to any aspect of the proposals referred to in this notice or as to...

Mereo BioPharma Sends Letter to Rubric Capital Management - Vimarsana News

Mereo BioPharma Sends Letter to Rubric Capital Management

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Bulletin from the annual general meeting in Alligator Bioscience AB on June 1, 2021 - Vimarsana News

Bulletin from the annual general meeting in Alligator Bioscience AB on June 1, 2021

/PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that the annual general meeting was held in the company this day. In light of...

Alligator Bioscience AB: Interim report January-March 2021 - Vimarsana News

Alligator Bioscience AB: Interim report January-March 2021

                                                                                                           High activity during the first quarter "So far, 2021 has been characterized by high activity, with a research collaboration that validates our Discovery concept, and good progress of our clinical programs, with ATOR-1017 and mitazalimab entering clinical efficacy studies this year." Malin Carlsson, Interim CEO Alligator Bioscience AB SIGNIFICANT EVENTS JANUARY-MARCH Pipeline: New ...